A federal court ruled pharmaceutical manufacturers can’t withhold upfront 340B drug discounts without federal approval, but left the door open to rebate models. Judge Dabney Friedrich with the U ...

Drugmakers have to continue paying hospitals upfront discounts for drugs in the 340B program — at least in the near term — after a federal court ruled late last week against major ...

The 340B program is criticized for generating revenue rather than solely aiding underinsured patients, impacting community providers and Medicare patients. Pharmaceutical companies face challenges ...

A federal judge has upheld HHS authority to oversee and regulate proposals to the 340B Drug Pricing Program, rejecting efforts of several major pharmaceutical companies to impose rebate-based ...

The 340B Drug Pricing Program has grown significantly since it was established in 1994, drawing increased scrutiny as it has expanded. More than $66 billion dollars were spent on outpatient drugs ...

Reputable Apple leaker Sonny Dickson shared a first look at a prototype pair of Powerbeats Pro 2 in a transparent colorway. Apple initially debuted the Powerbeats Pro 2 back in February ...

In the comments, users joked that it’s a new transparent cellphone. As it turns out, there is a much simpler (although maybe still just as odd) explanation for the phenomenon. According to the ...

The Medicare 340B programme has become a major flashpoint in the debate about drug pricing, and preventing 340B abuse has become a cause celebre for the pharma industry and its lobbyists.

These hospitals not only avoid nearly all taxes — they also reap billions of dollars in financial benefits from a federal prescription drug program known as 340B. The 340B drug discount program was ...

Advertisement ...